---
title: "300858.SZ (300858.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300858.SZ/news.md"
symbol: "300858.SZ"
name: "300858.SZ"
parent: "https://longbridge.com/en/quote/300858.SZ.md"
datetime: "2026-05-21T01:50:31.404Z"
locales:
  - [en](https://longbridge.com/en/quote/300858.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300858.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300858.SZ/news.md)
---

# 300858.SZ (300858.SZ) — Related News

### [Scitop Bio: Plans to repurchase shares for 100-150 million yuan, has not yet been implemented as of April 30](https://longbridge.com/en/news/285709389.md)
*2026-05-08T10:48:03.000Z*
> Scitop Bio announced that on April 20, 2026, the company plans to use its own funds to repurchase shares through a centr

### [Scitop Bio: Shareholders plan to reduce their holdings by no more than 2% of the company's shares](https://longbridge.com/en/news/284415308.md)
*2026-04-28T15:22:58.000Z*
> On April 28, Scitop Bio announced that its shareholder Ningbo Shunyi Venture Capital Partnership, which holds 6.08% of t

### [Overview of A-share Stock Buybacks: 31 Companies Disclose Buyback Progress](https://longbridge.com/en/news/283569620.md)
*2026-04-21T23:31:28.000Z*
> On April 22, 31 companies announced their stock repurchase progress, among which 16 companies disclosed their repurchase

### [Scitop Bio: Plans to use no more than 150 million yuan to repurchase company shares](https://longbridge.com/en/news/283503222.md)
*2026-04-21T12:48:56.000Z*
> Scitop Bio announced that it plans to use its own funds to repurchase a portion of the company's publicly held shares th

### [Scitop Bio released its first-quarter performance, with a net profit attributable to the parent company of 14.9513 million yuan, a decrease of 26.46%](https://longbridge.com/en/news/283503196.md)
*2026-04-21T12:48:47.000Z*
> Scitop Bio released its first quarter report for 2026, with operating revenue of 84.9959 million yuan, a year-on-year in

### [Scitop Bio: Revenue of 366 million yuan in 2025, net profit slightly increased by 0.17% year-on-year](https://longbridge.com/en/news/283497852.md)
*2026-04-21T12:17:09.000Z*
> Scitop Bio announced that in 2025, the company achieved operating revenue of 365.9227 million yuan, a year-on-year incre

### [Caitong Securities: The industrialization of microbial protein is accelerating, and the "big food perspective" is driving industry development](https://longbridge.com/en/news/281842580.md)
*2026-04-07T07:20:25.000Z*
> Caitong Securities released a research report indicating that the industrialization of microbial protein is accelerating

### [](https://longbridge.com/en/news/280942016.md)
*2026-03-30T02:12:52.000Z*
> The A-share dairy sector fluctuated and strengthened, with JINJIAN CEREALS INDUSTRY and XTAD both hitting the daily limi

### [Limit-up review: Lithium battery and pharmaceuticals lead the rise, YOUNGY hits 4 consecutive limit-ups and Scitop Bio reaches a 20% limit-up, where is the capital shifting as green energy retreats!](https://longbridge.com/en/news/280771707.md)
*2026-03-27T10:27:17.000Z*
> On March 27th, the market opened low and rose high, with the Shenzhen Component Index increasing by over 1%. The trading